资源描述:
《Current Topics in Medicinal医学课题》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、CurrentTopicsinMedicinalChemistry2002,2,903-913903MedicinalChemistryandMolecularPharmacologyofGABACReceptorsGrahamA.R.Johnston*AdrienAlbertLaboratoryofMedicinalChemistry,DepartmentofPharmacology,TheUniversityofSydney,NSW,2006,AustraliaAbstract:GABACreceptorsbelongtothenicotinicoidsuperfamilyofiono
2、tropicreceptorsthatincludenicotinicacetylcholinereceptors,bicuculline-sensitiveGABAAreceptors,strychnine-sensitiveglycinereceptorsand5HT3serotoninreceptors.TheGABACreceptorconceptarosefrommedicinalchemicalstudiesofaconformationallyrestrictedanalogofGABA.ReceptorsmatchingthepredictedpropertiesofGAB
3、ACreceptorswereclonedfromtheretina.Postcloningstudiesrevealedtheuniquephysiologyandpharmacologyoftheserelativelysimplehomomericreceptors.ThreesubtypesofGABACreceptorshavebeenclonedfrommammaliansourcesandpharmaco-logicaldifferencesbetweenther1,r2andr3GABACreceptorshavebeendescribed.Thereisevidencef
4、orfunctionalGABACreceptorsintheretina,spinalcord,superiorcolliculus,pituitaryandthegutandtheirinvolvementinvision,aspectsofmemoryandsleep-wakingbehaviour.ThisreviewconcentratesonthemedicinalchemistryandmolecularpharmacologyofGABACreceptorsubtypesemphasisingpossiblenewinvestigationaltoolswithwhicht
5、oinvestigatefurtherGABACreceptorfunction.ThemostusefulcurrentlyavailableligandsthatshowsomeGABACreceptorsubtypeselectivityareTPMPA,P4PMA,imidazole-4-aceticacid,2-methyl-TACAand(±)-TAMP.KeyWords:GABAreceptors–chloridechannels–CACA–CAMP–TPMPAINTRODUCTIONbicuculline-sensitive,andGABABreceptorsthatwer
6、ebicuculline-insensitiveandactivatedbybaclofen.TheGABAmoleculecanadoptavarietyofdifferentlowenergyconformations.ThedesignanddevelopmentofItisnowknownthatGABAAandGABABreceptorsareGABAanalogsofrestrictedconformationshowedthatfundamentallydifferenttypesofreceptors.GABAAreceptorsdifferentconformations
7、ofGABAwerelikelytointeractareligand-gatedionchannelsmadeupofapentamericwithdifferentmacromoleculesthatrecogniseGABAinitsmixtureofproteinsubunits[4],whileGABABreceptorsarefunctionasaninhibitoryneurotransmitter[1].